Capecitabine: all 1,069 studies that test it
Page 10 of 11. Open to participants first (152), then studies with results posted, then the rest; newest registration first within each.
- Capecitabine or Observation After Surgery in Treating Patients With Biliary Tract CancerCompletedNCT00363584Phase 3
- Capecitabine and Radiation Therapy in Treating Young Patients With Newly Diagnosed, Nonmetastatic Brain Stem Glioma or High-Grade GliomaCompletedNCT00357253Phase 1
- Imatinib in Combination With Dacarbazine and Capecitabine in Medullary Thyroid CarcinomaTerminatedNCT00354523Phase 1/2
- Capecitabine,Oxaliplatin & Erbitux Given Throughout Multi-Modal Therapy for Locally Advanced Rectal AdenocarcinomaTerminatedNCT00353457Phase 2
- Primary Chemotherapy With Adriamycin/Cyclophosphamide(AC) vs Taxotere/Xeloda(TX) for Stage II and III Breast CancerCompletedNCT00352378Phase 3
- Etoposide, Oxaliplatin and Capecitabine in Advanced Hepatocellular Carcinoma (HCC)TerminatedNCT00351195Phase 2
- Gemcitabine, Oxaliplatin and Capecitabine in Patients With Advanced CholangiocarcinomaCompletedNCT00350961Phase 1/2
- 1stline Study Capecitabine Administered on Continuous Way Plus Oxaliplatin&Bevacizumab Every 2weeks in Metastatic CCR.CompletedNCT00345696Phase 2
- Study of Satraplatin With Capecitabine to Treat Advanced Solid MalignanciesTerminatedNCT00329329Phase 1
- Combination Study of a New Taxane and Capecitabine in Patients With Metastatic Breast CancerCompletedNCT00327743Phase 1/2
- Tolerance and Pharmacokinetics With Capecitabine 5 Out of 7 Days RegimenStatus unknownNCT00324610Phase 1/2
- Phase III Randomized Trial of Adjuvant XP Chemotherapy and XP/RT for Resected Gastric AdenocarcinomaCompletedNCT00323830Phase 3
- Gemcitabine and Capecitabine in Patients With Advanced Pancreatic CancerCompletedNCT00316420Phase 1
- Sequential Versus Combination Chemotherapy in Advanced Colorectal CarcinomaCompletedNCT00312000Phase 3
- Combined Treatment With Capecitabine and Immunotherapy Versus Immunotherapy Alone in Advanced Renal Cell CarcinomaTerminatedNCT00311467Phase 3
- Randomized Neoadjuvant Study of Epirubicin and Docetaxel With/Without Capecitabine in Early Breast CancerCompletedNCT00309556Phase 3
- Capecitabine as Second-Line Therapy in Treating Patients With Stage IV Pancreatic Cancer Who Have the Thymidylate Synthase GeneCompletedNCT00303927Phase 2
- Irinotecan With or Without Capecitabine as Second-Line Therapy in Treating Older Patients With Progressive, Metastatic Colorectal Cancer That Cannot Be Removed By SurgeryStatus unknownNCT00303745Phase 2
- Combination Chemotherapy in Treating Patients With Early Stage Breast Cancer That Has Been Removed By SurgeryStatus unknownNCT00301925Phase 3
- Preoperative Combined Radiochemotherapy for Patients With Rectal CarcinomaCompletedNCT00297141Phase 2
- Preoperative Chemoradiation With Capecitabine and CetuximabCompletedNCT00297128Phase 2
- Dose Dense Therapy and Bevacizumab in Solid Tumors and Colorectal CancerTerminatedNCT00296062Phase 1
- The MAX Study: Mitomycin C, Avastin and Xeloda in Patients With Untreated Metastatic Colorectal CancerCompletedNCT00294359Phase 2/3
- Combination Chemotherapy With or Without Capecitabine and/or Trastuzumab Before Surgery in Treating Women With Stage I, Stage II, or Stage III Breast CancerCompletedNCT00288002Phase 3
- Combination Chemotherapy and Radiation Therapy in Treating Patients With Esophageal Cancer or Gastroesophageal Junction CancerCompletedNCT00281788Phase 1
- Capecitabine Associated With Weekly Paclitaxel in Metastatic Breast Cancer.CompletedNCT00270491Phase 2
- Oxaliplatin in Combination With Capecitabine and Concurrent Radiation Therapy in Non-Small Cell Lung CancerTerminatedNCT00268151Phase 1
- Paclitaxel Poliglumex and Capecitabine in Treating Patients With Metastatic Breast CancerCompletedNCT00265733Phase 2
- Adjuvant Capecitabine in Elderly Patients With Breast Cancer: a Phase II StudyCompletedNCT00263705Phase 2
- Preoperative Radiotherapy/ Oxaliplatin/ Capecitabine Treatment For Unresectable Locally-advanced Rectal CancerCompletedNCT00263029Phase 2
- Capecitabine and Docetaxel in Treating Patients With Metastatic Prostate CancerCompletedNCT00258284Phase 2
- Celecoxib, Capecitabine, and Irinotecan in Treating Patients With Recurrent or Metastatic Colorectal CancerCompletedNCT00258232Phase 2
- Capecitabine and Docetaxel in Advanced/Recurrent Cervical CancerCompletedNCT00257348Phase 2
- Celecoxib/Oxaliplatin/Capecitabine for Gastric/Gastroesophageal Junction CarcinomaTerminatedNCT00256321Phase 2
- Cap/Iri Plus Cetuximab Compared to Cap/ox Plus Cetuximab in Patients With Metastatic Colorectal Cancer.CompletedNCT00254137Phase 2
- Imatinib Mesylate and Capecitabine in Treating Patients With Advanced Solid TumorsCompletedNCT00253565Phase 1
- First-Line Capecitabine and Cetuximab for Metastatic Colorectal Ca in Elderly PatientsTerminatedNCT00251186Phase 2
- IRESSA™ In Combo With Xeloda™ in Advanced Colorectal Cancer Patients After 1st-Line Chemo FailureCompletedNCT00242788Phase 1/2
- Combination Chemotherapy and Radiation Therapy in Treating Patients Who Are Undergoing Surgery for Locally Advanced Esophageal CancerCompletedNCT00238147Phase 1
- Combination Chemotherapy Treatments in Patients With Metastatic Colorectal CancerCompletedNCT00230399Phase 2
- Capecitabine and Oxaliplatin With or Without Cetuximab in Treating Patients With Metastatic Colorectal Cancer That Cannot Be Removed By SurgeryCompletedNCT00227734Phase 2
- Capecitabine and Pegylated Interferon Alfa-2a in Treating Patients With Recurrent or Progressive Brain Metastases Due to Breast CancerTerminatedNCT00227656Phase 2
- A Trial of Thalidomide and Capecitabine in Metastatic Renal Cell CarcinomaCompletedNCT00226980Phase 2
- Immunochemotherapy for Metastatic Renal Cell CarcinomaStatus unknownNCT00226798Phase 2
- Phase II Study of Capecitabine and Weekly Docetaxel Followed by Capecitabine Maintenance for Patients With Metastatic Breast CarcinomaTerminatedNCT00225056Phase 2
- Phase II Trial Evaluating Irinotecan and Capecitabine Relapsed/Refractory Upper GI TumoursCompletedNCT00220168Phase 4
- Neoadjuvant Epirubicin, Cisplatin and Capecitabine (ECX) Followed by Definitive Chemoradiation With/Without Surgery for Squamous Cell Carcinoma of the OesophagusCompletedNCT00220129Phase 2
- Phase II Trial Assessing Efficacy and Toxicity of Capecitabine and Oxaliplatin in the Treatment of Colorectal CancerCompletedNCT00220116Phase 2
- Pre-operative Epirubicin, Cisplatin, and Capecitabine in Patients With Newly Diagnosed Localised Oesophageal AdenocarcinomaCompletedNCT00220103Phase 2
- A Phase II Study of Oxaliplatin Capecitabine and Pre-operative Radiotherapy for Patients With Locally Advanced and Inoperable Rectal CancerCompletedNCT00220051Phase 2
- Oxaliplatin, Irinotecan, and Capecitabine in Treating Patients With Advanced or Metastatic Colorectal Cancer That Cannot Be Removed By SurgeryCompletedNCT00217711Phase 1/2
- Dose Escalation Study Combining Oral Capecitabine (Xeloda) and Radiotherapy for Patients With Unresectable Liver or CholangiocarcinomaTerminatedNCT00216437Phase 1
- Capecitabine (Xeloda) and Radiation for Patients With Rectosigmoid CarcinomaTerminatedNCT00216424Phase 4
- Docetaxel and Capecitabine for First Line Treatment of Metastatic Squamous Cell Carcinoma of the Head & NeckTerminatedNCT00216138Phase 2
- Capecitabine, Oxaliplatin and Trastuzumab in Treating Patients With HER2 Positive Metastatic Breast CancerTerminatedNCT00216073Phase 2
- Capecitabine and Oxaliplatin in Treating Patients With Metastatic Breast CancerCompletedNCT00216021Phase 2
- Study of Capecitabine With Irinotecan and Oxaliplatin (Eloxatin) in Advanced Colorectal CancerCompletedNCT00215982Phase 2
- Capecitabine or 5-Fluorouracil in Combination With Irinotecan and Cisplatin in Patients With Solid Tumor MalignanciesCompletedNCT00215501Phase 1
- A Study of Weekly Taxotere and Xeloda in Metastatic Breast CancerCompletedNCT00214864Phase 2
- XELOX III. Xeloda in Combination With Eloxatin for Patients With Advanced or Metastatic Colorectal CancerCompletedNCT00212615Phase 2/3
- Patients Preference for Oral or i.v. TherapyCompletedNCT00212589Phase 3
- Effect of Capecitabine on the Pharmacokinetics of BMS-247550 and BMS-247550 on the Pharmacokinetics of Capecitabine and Its Metabolites in Patients With Advanced MalignanciesCompletedNCT00207129Phase 1
- XELOX for Metastatic Breast CancerCompletedNCT00204776Phase 2
- Genomic & Proteomic Analysis of Docetaxel & Capecitabine as Primary Chemo for Stage II-III Breast CancerCompletedNCT00198237Phase 2
- A Study to Compare ETC vs. EC-TX and Ibandronate vs. Observation in Patients With Node-positive Primary Breast Cancer (GAIN)CompletedNCT00196872Phase 3
- Study in Elderly Patients With Early Breast Cancer (ICE)CompletedNCT00196859Phase 3
- Mono Efficacy of Capecitabine (MoniCa)CompletedNCT00196820Phase 2
- Weekly Vinorelbine and Oral Capecitabine as Treatment for Stage IV Breast CancerCompletedNCT00194727Phase 2
- Thalidomide in Combination With Capecitabine in Patients With Metastatic Breast CancerTerminatedNCT00193102Phase 2
- Concurrent Xeloda and Radiotherapy for Bone MetastasesStatus unknownNCT00192777Phase 2
- Phase III Study of Gemcitabine Plus a Cytotoxic Agent Versus Two Cytotoxic AgentsCompletedNCT00191438Phase 3
- Study of Xeloda and Gleevec in Patients With Advanced Solid TumorsCompletedNCT00183833Phase 1
- Radiation Therapy With Capecitabine in Rectal CancerTerminatedNCT00176787Phase 2
- Capecitabine and Radiation Therapy in Advanced Pancreatic CancerTerminatedNCT00176735Not applicable
- CORE: Capecitabine, Oxaliplatin, Radiotherapy and ExcisionCompletedNCT00174616Phase 2
- Safety Study of a New Schedule of Capecitabine and Docetaxel to Treat CancersCompletedNCT00169000Phase 1
- Capecitabine and Thalidomide in Previously Treated Metastatic Colorectal CarcinomaCompletedNCT00165217Phase 2
- Genes as Predictors of Response to Gemcitabine, Docetaxel, and Capecitabine (GTX) in Metastatic or Unresectable Pancreatic Cancer.TerminatedNCT00159471Not applicable
- Capecitabine and Gemcitabine in Patients With Metastatic Colorectal CancerCompletedNCT00159445Phase 2
- Oxaliplatin and Capecitabine Versus Follow-up After Resection of Colorectal Liver MetastasesStatus unknownNCT00156975Phase 3
- Evaluation of Tumor Factors in Breast Cancer Treated With Docetaxel and CapecitabineCompletedNCT00156312Not applicable
- Docetaxel, Cisplatin and Capecitabine as Neoadjuvant Chemotherapy for Locally Advanced Breast CancerCompletedNCT00155259Phase 2
- Navelbine and Capecitabine in the Treatment of Metastatic Breast CancerCompletedNCT00153907Phase 1
- Docetaxel and Carboplatin Followed by Oral Capecitabine, Docetaxel and Radiation for Esophageal CancerCompletedNCT00153881Phase 1
- Docetaxel Plus Capecitabine in Newly Diagnosed Localized or Locally Advanced Prostate CancerCompletedNCT00151047Phase 2
- Capecitabine in Women With Operable Breast CancerTerminatedNCT00148720Phase 2
- Combination of Carboplatin, Gemcitabine, and Capecitabine in Patients With Carcinoma of Unknown Primary SiteTerminatedNCT00148135Phase 2
- Cytoxan, Epirubicin and Capecitabine in Women With Breast CancerCompletedNCT00146588Not applicable
- Capecitabine, Oxaliplatin, Bevacizumab and Radiation Therapy in Patients With Biliary Tract and Gallbladder CancerCompletedNCT00142480Phase 2
- Docetaxel and Capecitabine in Advanced Gastric CancerCompletedNCT00142038Phase 2
- Study of Epirubicin (Pharmorubicin®), Carboplatin (Paraplatin®) and Capecitabine (Xeloda®) (ECC) in the Treatment of Unresectable Locally Advanced or Metastatic Gastric/Gastroesophageal Junction Cancer With Pharmacogenetic CorrelatesTerminatedNCT00130936Phase 1/2
- Tarceva and Capecitabine for Pancreatic CancerCompletedNCT00125021Phase 2
- Study of Irofulven in Patients With Hormone-refractory Prostate CancerCompletedNCT00124566Phase 2
- Study of Irofulven Plus Capecitabine in Patients With Advanced Thyroid CancerCompletedNCT00124527Phase 2
- Tarceva, Capecitabine and Oxaliplatin for Metastatic Colorectal CancerCompletedNCT00123851Phase 2
- A Study of Preoperative Radiation Therapy and Capecitabine in Locally Advanced Rectal CancerStatus unknownNCT00122291Phase 2
- Vorinostat and Capecitabine in Treating Patients With Metastatic or Unresectable Solid TumorsCompletedNCT00121277Phase 1
- Study of Oxaliplatin, Capecitabine, and Bevacizumab to Treat Older Patients With Colorectal CancerTerminatedNCT00120172Phase 2
- Gemcitabine, Docetaxel, and Capecitabine in Treating Patients With Cancer of Unknown Primary OriginWithdrawnNCT00119314Phase 2
- Ispinesib In Combination With Capecitabine In Patients With Solid TumorsCompletedNCT00119171Phase 1